Heart surgery showdown: which solution saves more heart muscle?
NCT ID NCT07637266
First seen Jun 12, 2026 · Last updated Jun 20, 2026 · Updated 2 times
Summary
This study compares two solutions used to protect the heart during coronary artery bypass surgery: standard blood cardioplegia and del Nido cardioplegia. Researchers will use MRI scans to see which solution better preserves heart muscle. The trial involves 60 adults with multivessel coronary artery disease scheduled for elective bypass surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Center Zagreb
RECRUITINGZagreb, 10000, Croatia
-
University Hospital Center Zagreb
RECRUITINGZagreb, 10000, Croatia
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Del Nido cardioplegia solution and blood cardioplegia solution
What this could lead to
If one solution proves better, it could guide surgeons toward a safer method for protecting the heart during bypass surgery.
What could go wrong
This is a small, early-stage study with only 60 patients, so results may not apply to everyone. The main goal is to gather knowledge, not to prove a new treatment works.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.